Vertex Pharmaceuticals
VRTX
#201
Rank
C$162.40 B
Marketcap
C$639.87
Share price
-1.60%
Change (1 day)
4.20%
Change (1 year)

Earnings for Vertex Pharmaceuticals (VRTX)

Earnings in 2026 (TTM): C$6.97 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's current earnings are C$12.21 Billion. In 2025 the company made an earning of C$7.01 Billion, an increase over its 2024 earnings that were of C$0.39 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vertex Pharmaceuticals from 1990 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$6.97 B-0.64%
2025 C$7.01 B1675.06%
2024 C$0.39 B-93.69%
2023 C$6.26 B3.19%
2022 C$6.07 B53.56%
2021 C$3.95 B-12.06%
2020 C$4.49 B118.45%
2019 C$2.05 B120.64%
2018 C$0.93 B1473.64%
2017 C$59.3 M197.6%
2016 C$19.92 M-102.97%
2015 -C$0.68 Billion-28.46%
2014 -C$0.94 Billion-51.5%
2013 -C$1.94 Billion-30584.68%
2012 C$6.34 M-95.47%
2011 C$0.14 B
2009 -C$0.84 Billion
2007 -C$0.59 Billion83.1%
2006 -C$0.32 Billion59.02%
2005 -C$0.21 Billion3.28%
2004 -C$0.2 Billion-38.16%
2003 -C$0.32 Billion
2000 -C$53.9 Million-20.38%
1999 -C$67.7 Million31.62%
1998 -C$51.44 Million91.05%
1997 -C$26.92 Million-36.24%
1996 -C$42.23 Million12.45%
1995 -C$37.55 Million27.4%
1994 -C$29.47 Million-1833.33%
1993 C$1.7 M-112.12%
1992 -C$14.03 Million175%
1991 -C$5.11 Million-12.2%
1990 -C$5.81 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.80 B 413.23%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$9.34 B 30.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$13.88 B 93.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$18.63 B 159.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$13.59 B 89.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
-C$0.11 Billion-101.50%๐Ÿ‡บ๐Ÿ‡ธ USA